E. Ohman J:or Asset Management AB

Position in ABBV — AbbVie Inc.

CIK 2009396 STOCKHOLM, V7

Position in ABBV

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$15,692,773

+$2,619,015 QoQ

Shares Held

62,362

+3.7% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#720

of 4,153 holders

Holding Since

Mar 2020

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

E. Ohman J:or Asset Management AB holds $142,928,858 across 9 Drug Manufacturers - General names. ABBV ranks #2 (11.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	65,270	$78,286,802
2	ABBV	AbbVie Inc. This page	62,362	$15,692,773
3	JNJ	Johnson & Johnson	59,384	$15,081,754
4	MRK	Merck & Co., Inc.	87,897	$11,294,764
5	AMGN	Amgen Inc	19,515	$7,066,771
6	GILD	Gilead Sciences, Inc.	44,792	$5,659,021
7	PFE	Pfizer Inc	199,117	$4,794,737
8	BMY	Bristol Myers Squibb Co	69,612	$4,011,043

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$15,692,773	62,362	+3.7%	Shares	Sole	2026-07-10
2026-03-31	$13,073,758	60,112	-3.2%	Shares	Sole	2026-04-16
2025-12-31	$14,191,970	62,112	-72.6%	Shares	Sole	2026-01-12
2022-12-31	$36,667,531	226,889	-11.0%	Shares	Sole	2024-04-05
2022-09-30	$34,209,994	254,899	-3.7%	Shares	Sole	2024-04-05
2022-06-30	$40,522,613	264,577	-3.5%	Shares	Sole	2024-04-05
2022-03-31	$44,445,212	274,167	+753.9%	Shares	Sole	2024-04-05
2021-12-31	$4,347,287	32,107	-59.4%	Shares	Sole	2024-04-05
2021-09-30	$8,522,485	79,007	+3.3%	Shares	Sole	2024-04-05
2021-06-30	$8,617,748	76,507	+8.1%	Shares	Sole	2024-04-05
2021-03-31	$7,662,733	70,807	+96.6%	Shares	Sole	2024-04-05
2020-12-31	$3,858,150	36,007	-7.0%	Shares	Sole	2024-04-05
2020-09-30	$3,390,346	38,707	-5.6%	Shares	Sole	2024-04-05
2020-06-30	$4,026,067	41,007	+18.9%	Shares	Sole	2024-04-05
2020-03-31	$2,628,555	34,500	—	Shares	Sole	2024-04-05
No filing history on record for this holder in this stock.